Beam Therapeutics
AWARDS
NEWS
Biotech and pharma companies strengthen their leadership teams and boards of directors with this week’s appointments.
There is, thankfully, no age limit on innovation—you can do it at any age. But for many, “young,” counts as under 30, sometimes under 35, or even under 40, at least in terms of putting together lists of scientific innovators.
Both companies said they plan to work together in order to strengthen their competitive positions.
Biopharma companies add new leaders to executive roles and boards of directors.
Beam Therapeutics is one of BioSpace’s NextGen Bio “Class of 2019” Life Science Startups to Watch in 2019.
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.
JOBS
IN THE PRESS